| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |